sofidexFor patientsAre you a clinician? Clinical site

Meds & supplements  ›  Rifaximin

Medicine · Rifamycin Antibacterial

Rifaximin

To reduce the development of drug-resistant bacteria and maintain the effectiveness of XIFAXAN and other antibacterial drugs, XIFAXAN when used to treat infection should be used only to treat or prevent infections that are proven or…

Prescribing label

Selected manufacturer label information, organised into consistent sections by Sofidex. This source is written for healthcare professionals; ask your pharmacist to explain instructions that are unclear. Read the full label at DailyMed ↗

Drug facts

Used for
  • When culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy.
  • In the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy.
Do not take if
  • XIFAXAN is contraindicated in patients with a hypersensitivity to rifaximin, any of the rifamycin antimicrobial agents, or any of the components in XIFAXAN.
  • Hypersensitivity reactions have included exfoliative dermatitis, angioneurotic edema, and anaphylaxis.

What it is used for

To reduce the development of drug-resistant bacteria and maintain the effectiveness of XIFAXAN and other antibacterial drugs, XIFAXAN when used to treat infection should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. When culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. In the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy.

Side effects, and when to stop

The following clinically significant adverse reactions are described elsewhere in labeling:

  • Clostridium difficile -associated diarrhea [ see Warnings and Precautions ( 5.2 )]

Who should not take it

XIFAXAN is contraindicated in patients with a hypersensitivity to rifaximin, any of the rifamycin antimicrobial agents, or any of the components in XIFAXAN. Hypersensitivity reactions have included exfoliative dermatitis, angioneurotic edema, and anaphylaxis.

Cite this page

NLM

sofidex [Internet]. Daloreum; c2026. Rifaximin; [reviewed 2026 Aug 3; cited 2026 Nov 10]. Available from: https://sofidex.com/patients/medicines/rifaximin

APA 7th

sofidex. (2026, August 3). Rifaximin. Daloreum. Retrieved November 10, 2026, from https://sofidex.com/patients/medicines/rifaximin

AMA 11th

Rifaximin. sofidex. Reviewed August 3, 2026. Accessed November 10, 2026. https://sofidex.com/patients/medicines/rifaximin

The cited date is today’s, because a citation records when you read the page. The reviewed date is when a clinician last checked it.